A patient came into the clinic last week frustrated. She runs a team of fifteen. She has not missed a quarterly target in six years. And she could not understand why her body had stopped responding to the same routine that had carried her through her 30s and 40s.
"I'm eating less. I'm doing more cardio. Nothing is working."
She is not undisciplined. She is in the metabolic transition of perimenopause, and the rules her body used to play by have changed.
This is the conversation I have most often with women at the top of their fields. The frustration is not about vanity. It is about losing access to the energy and clarity they built their careers on. And it is hitting at the exact moment the rest of their lives are also asking the most of them.
The science is finally catching up to what these women have been experiencing. So is the law. In late May 2026, the Illinois legislature passed House Bill 5284, the Illinois Menopause Equity and Care Act, which will require employers to provide menopause-related accommodations and expand insurance coverage for menopause care. As of this writing, the bill is on the Governor's desk. The workplace and education provisions are scheduled to take effect January 1, 2027, with the insurance provisions following on January 1, 2028.
For high-performing women and the people who lead them, this is the moment to understand what is actually happening, and what to do about it.
What changes in the body
Estrogen does more than govern reproduction. It is a quiet metabolic regulator. It influences where the body stores fat, how cells respond to insulin, how muscle is built and maintained, and how mood, sleep, and cognition are coordinated.
When estrogen drops in perimenopause and beyond, three things shift quickly.
First, fat distribution. Premenopausal estrogen keeps fat largely in the hips and thighs as subcutaneous tissue, which is metabolically quiet. After menopause, fat starts parking at the waistline as visceral fat, packing in around the liver, pancreas, and intestines. Visceral fat is biologically active and inflammatory. It drives insulin resistance directly.
Second, insulin sensitivity. The same meal that produced a clean glucose curve at 35 now triggers a larger insulin response at 52. Higher chronic insulin levels mean the body stays in storage mode instead of fat-burning mode. The waistline grows, which worsens insulin resistance, which grows the waistline. The cycle is self-reinforcing, and the markers that catch it early (a fasting insulin above 7 or 8, a triglyceride-to-HDL ratio above 2, an A1c at 5.7 or higher) often get missed on standard panels.
Third, muscle maintenance. Estrogen contributes to muscle protein synthesis. Without it, the protein threshold required to maintain muscle goes up. Younger women might preserve muscle on 15 grams of protein per meal. Midlife women need closer to 30 grams per meal to stimulate the same response. This is the well-documented "leucine threshold" for older adults, generally around 2.5 to 2.8 grams of leucine per meal, which is what you get from roughly 30 grams of high-quality protein.
The combined effect is that the woman who used to drop a few pounds on a calorie cut and a few extra cardio sessions now does the same routine and loses muscle instead of fat. Body composition gets worse while the scale either holds steady or drops in a way that looks encouraging.
What it looks like at work
The metabolic shift is not just a body composition story. It is a performance story.
Insulin resistance is associated with brain fog, fatigue, mood instability, and disrupted sleep. Visceral fat raises systemic inflammation. Add in the hot flashes, night sweats, and sleep fragmentation that come with perimenopause, and the senior leader on your team is doing her work on three hours of consolidated sleep and a body that is signaling crisis.
She does not look any different. She is still showing up. And she is quietly working at a fraction of her usual capacity, often blaming herself for it.
Research from Mayo Clinic and others has documented significant lost productivity, missed promotions, and workforce exit costs tied to untreated menopause symptoms. The methodologies and dollar figures vary, but the pattern is consistent: women in their peak career years are temporarily losing capacity at the moment their organizations need them most.
This is the gap that Illinois HB 5284 is trying to close.
What Illinois just did
The Illinois Menopause Equity and Care Act, House Bill 5284, was introduced by State Representative Yolonda Morris in February 2026. It passed the House 78 to 33 in late April, and was approved by the Senate on May 21, 2026, presented on the Senate floor by Senate Majority Leader Kimberly Lightford. As of early June 2026, the bill is awaiting the Governor's signature.
The bill does three things.
It amends the Illinois Human Rights Act to make menopause-related conditions a basis for reasonable workplace accommodations. Employers will be required to consider requests for flexible scheduling, modified hours, temperature-controlled workspaces, private spaces for symptom management, remote work options, and light duty assignments when feasible. The framework parallels how pregnancy-related accommodations are already handled in Illinois.
It amends the state insurance code to require coverage for the medical evaluation and treatment of perimenopause and menopause, including hormone therapy and osteoporosis medications. Many women have been paying out of pocket for menopause care, particularly hormone replacement, because coverage was inconsistent or absent.
It requires the Illinois Department of Public Health to develop and distribute educational materials for the public and voluntary educational resources for clinicians, addressing what is still a striking gap in primary care training around menopause management.
The workplace and education provisions take effect January 1, 2027. The insurance provisions follow on January 1, 2028.
For employers, the practical implication is that menopause accommodations are moving from "nice to do" to "required under the Human Rights Act." For employees, conversations about flexibility around symptom management will have legal standing.
For high performers in particular, the legislation is an opening. The accommodations are not designed for women who are struggling to keep up. They are designed for women who are still leading, and who deserve infrastructure that protects their capacity.
What actually helps
The medical playbook for this stage of life is not exotic. It is specific.
Protein at 30 grams or more per meal. The threshold matters more than the daily total. Spacing protein across three to four anchored meals gives the body repeated opportunities to maintain muscle. A simple rule that holds up at restaurants and airports: the size and thickness of your palm, minus fingers and thumb, is roughly one serving of protein. Three to four of those per day.
Strength training, two short sessions a week. Ten minutes is enough if you actually load the major muscle groups until they burn. The point is the signal, not the volume. Skipping this is what costs women muscle in perimenopause and postmenopause. Cardio alone will not do it. Whole-body vibration platforms (the power plate is the most studied) can compress the work further by recruiting many muscle fibers simultaneously, with established evidence in bone density and rehabilitation.
Less grazing. The wellness advice to "eat small frequent meals" is generally counterproductive in midlife. Each eating occasion triggers an insulin response. Snacking through the day keeps insulin elevated and signals the body to store, even when the calories are low. Three meals with adequate protein, ending several hours before bed, give the body the time it needs to access fat-burning mode.
Sleep, protected as best you can. Perimenopausal sleep fragmentation is real and frustrating. One of the most useful research findings here is that worry about not sleeping is associated with more biological harm than the missed sleep itself. Protect the time. Let the body do what it can with it.
Targeted medications when appropriate. Metformin is well established for insulin resistance and can be transformative when a fasting insulin is elevated. GLP-1 medications such as semaglutide and tirzepatide are powerful and effective, and they require an informed plan to avoid the muscle loss that is otherwise rapid in midlife users. Up to 40% of weight lost on GLP-1s can be muscle, particularly in older women, which is why protein and strength training become non-negotiable on these medications. New options are coming, including triple agonists such as retatrutide, which is still in Phase 3 trials and targets visceral fat and liver fat directly. None of these medications substitute for the protein and strength training foundation. They amplify what the foundation makes possible.
Lab work most panels miss. Ask for a fasting insulin, a triglyceride-to-HDL ratio, and a hemoglobin A1c. A fasting insulin above 7, a TG/HDL ratio above 2, or an A1c at 5.7 or higher is worth investigating, even when every other number looks normal.
Where this goes
The women navigating perimenopause and menopause right now are the most senior, most experienced workforce we have ever had. They are also the first cohort to enter midlife with both the clinical tools and the policy framework to do this on their own terms.
The combination of better physiology, better medications, and protective legislation is the playbook update that has been missing for a generation.
If you are a high performer feeling like your body has stopped responding to the routine that built your career, you are not imagining it. The body's rules changed. The instructions need to change with them.
If you are an employer in Illinois, the question is no longer whether to think about menopause in the workplace. It is how to do it well, and on what timeline.
The body keeps trying to repair and rebuild, no matter the decade. What is finally changing is the support around it.
To talk about clinical care, organizational support, or speaking on this topic, reach out through drnaomiparrella.com.